Latest team publications
-
Stéphane Dalle, Estelle Verronese, Axelle N’kodia, Christine Bardin, Céline Rodriguez, et al.. Modulation of blood T cell polyfunctionality and HVEM/BTLA expression are critical determinants of clinical outcome in anti-PD1-treated metastatic melanoma patients. OncoImmunology, 2024, 13 (1), pp.2372118. ⟨10.1080/2162402X.2024.2372118⟩. ⟨hal-04632685⟩
-
-
Anthony Di Roio, Margaux Hubert, Laurie Besson, Marion Bossennec, Céline Rodriguez, et al.. MDR1-expressing CD4+T cells with Th1.17 features resist to neoadjuvant chemotherapy and are associated with breast cancer clinical response. Journal for Immunotherapy of Cancer, 2023, 11 (11), ⟨10.1136/jitc-2023-007733⟩. ⟨hal-04379561⟩
-
Benjamin Ducarouge, Anna-Rita Redavid, Camille Victoor, Ruxanda Chira, Aurélien Fonseca, et al.. Netrin-1 blockade inhibits tumor associated Myeloid-derived suppressor cells, cancer stemness and alleviates resistance to chemotherapy and immune checkpoint inhibitor. Cell Death and Differentiation, 2023, 30 (10), pp.2201-2212. ⟨10.1038/s41418-023-01209-x⟩. ⟨hal-04253805⟩
-
-
Lise Mangiante, Nicolas Alcala, Alexandra Sexton-Oates, Alex Di Genova, Abel Gonzalez-Perez, et al.. Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity. Nature Genetics, 2023, 55 (4), pp.607-618. ⟨10.1038/s41588-023-01321-1⟩. ⟨inserm-04062865⟩